XM does not provide services to residents of the United States of America.
M
M

MontedeiPaschi

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Italy - Factors to watch on Nov. 21

Italy - Factors to watch on Nov. 21 The following factors could affect Italian markets on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . POLITICS European Parliament leaders reached agreement on Wednesday on the composition of the next European Commission, including Italy's Raffaele Fitto, clearing the way for the new EU executive to take office nex
A
E
I
A
B
M
T
T
I
U

Anima held 4% in Italy's Monte Paschi as of Nov. 13, filing shows

BRIEF-Anima held 4% in Italy's Monte Paschi as of Nov. 13, filing shows Nov 20 (Reuters) - Italy's watchdog CONSOB on its website: ANIMA HOLDING HELD 3.992% STAKE IN BANCA MONTE DEI PASCHI AS OF NOV. 13, FILING SHOWS ITALIAN TYCOON FRANCESCO GAETANO CALTAGIRONE HELD 4.972% STAKE IN BANCA MONTE DEI PASCHI AS OF NOV. 13, FILING SHOWS DEL VECCHIO FAMILY HOLDING COMPANY DELFIN HELD 3.509% STAKE IN BANCA MONTE DEI PASCHI AS OF NOV.
A
B
M

Italy - Factors to watch on Nov. 15

Italy - Factors to watch on Nov. 15 The following factors could affect Italian markets on Friday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . ECONOMY ISTAT releases October CPI final data (0900 GMT) and September foreign trade data (1000 GMT).
E
P
U
A
A
B
F
M
P
I
U

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Updates Capri, Ovintiv; Adds Reliance, Aixigo, Paramount Resources, Diligent, Evotec Nov 14 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2130 GMT on Thursday: * * German drugmaker Evotec EVTG.DE is attracting takeover interest from U.S.-based Halozyme Therapeutics HALO.O , Bloomberg News reported on Thursday.
M

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Tapestry, General Mills Updates: Ovintiv Nov 14 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Thursday: ** Tapestry TPR.N is terminating its $8.5 billion deal to buy Michael Kors owner Capri CPRI.N following a legal hurdle, the companies said, ending their effort to create a U.S.
M

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.